menu
    • menu
    [{"orgOrder":0,"company":"Global Stem Cell Technology","sponsor":"Boehringer Ingelheim GmbH","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"BELGIUM","productType":"Cell and Gene therapy","year":"2020","type":"Acquisition","leadProduct":"Mesenchymal stem cell therapy","moa":"","graph1":"Immunology","graph2":"Approved","graph3":"Global Stem Cell Technology","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"","sponsorNew":"Global Stem Cell Technology \/ Boehringer Ingelheim","highestDevelopmentStatusID":"12","companyTruncated":"Global Stem Cell Technology \/ Boehringer Ingelheim"}]

    Find Clinical Drug Pipeline Developments & Deals by Global Stem Cell Technology

    Menu

    Global Stem Cell Technology

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Global Stem Cell Technology

                            Belgium arrow
                            Antibody Engineering
                            Not Confirmed

                            Global Stem Cell Technology

                            Belgium arrow
                            Antibody Engineering
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Mesenchymal stem cell therapy

                            Therapeutic Area : Immunology

                            Study Phase : Approved

                            Sponsor : Boehringer Ingelheim GmbH

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Boehringer Ingelheim Acquires GST to Strengthen its Stem Cell Capabilities in Animal Health

                            Details : The acquisition follows two years of successful partnership that brought the first-ever registered stem cell-based veterinary medicine to the European market.

                            Brand Name : Arti-Cell

                            Molecule Type : Cell and Gene therapy

                            Upfront Cash : Undisclosed

                            July 27, 2020

                            Lead Product(s) : Mesenchymal stem cell therapy

                            Therapeutic Area : Immunology

                            Highest Development Status : Approved

                            Sponsor : Boehringer Ingelheim GmbH

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth